Skip to main content
Clinical Trials/TCTR20200622005
TCTR20200622005
Completed
Phase 1

Perioperative versus Postoperative Oral Calcium and Vitamin D Supplement to Prevent Symptomatic Hypocalcemia after Total Thyroidectomy: A Randomized Controlled Trial

one0 sites160 target enrollmentJune 22, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients who underwent total or completion thyroidectomy from June 1st, 2017 to June 30th, 2020 at the department of otolaryngology, Maharaj Nakorn Chiang Mai Hospital
Sponsor
one
Enrollment
160
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 22, 2020
End Date
May 31, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • Patients who underwent total or completion thyroidectomy

Exclusion Criteria

  • 1\. Patients who have parathyroid diseases of hypoparathyroidism preoperatively
  • 2\. Abnormal serum calcium (normal range 8\.5\-10\.2 mg/dl)
  • 3\. Abnormal serum phosphate (normal range 2\.5\-4\.5 mg/dl)
  • 4\. Abnormal serum magnesium (normal range 1\.32\-2\.14 mEq/L)
  • 5\. Abnormal creatinine clearance \>60 ml/min
  • 6\. Abnormal liver function (Total bilirubin \>1\.5 mg/dl, AST \>40 U/L, ALT \>41 U/L, alkaline phosphatase \>129 U/L)
  • 7\. Patients with underlying heart diseases
  • 8\. Patients who currently breast feeding or pregnancy
  • 9\. Patients who have calcium or vitamin D as current medications

Outcomes

Primary Outcomes

Not specified

Similar Trials